AbbVie Presents New Analyses Evaluating RINVOQ (upadacitinib) in Atopic Dermatitis Across Patient Characteristics and Body Regions at EADV Virtual Congress

Mount Carmel Register

Sep 30, 2021

AbbVie Presents New Analyses Evaluating RINVOQ (upadacitinib) in Atopic Dermatitis Across Patient Characteristics and Body Regions at EADV Virtual Congress |!| Mount Carmel